GURUFOCUS.COM » STOCK LIST » Consumer Cyclical » Furnishings, Fixtures & Appliances » Kewaunee Scientific Corp (STU:KEW) » Definitions » Operating Income

Kewaunee Scientific (STU:KEW) Operating Income : €14.2 Mil (TTM As of Jan. 2024)


View and export this data going back to 2007. Start your Free Trial

What is Kewaunee Scientific Operating Income?

Kewaunee Scientific's Operating Income for the three months ended in Jan. 2024 was €3.5 Mil. Its Operating Income for the trailing twelve months (TTM) ended in Jan. 2024 was €14.2 Mil.

Warning Sign:

Kewaunee Scientific Corp has recorded a loss in operating income at least once over the past 3 years.

Operating Margin % is calculated as Operating Income divided by its Revenue. Kewaunee Scientific's Operating Income for the three months ended in Jan. 2024 was €3.5 Mil. Kewaunee Scientific's Revenue for the three months ended in Jan. 2024 was €42.9 Mil. Therefore, Kewaunee Scientific's Operating Margin % for the quarter that ended in Jan. 2024 was 8.05%.

Kewaunee Scientific's 5-Year average Growth Rate for Operating Margin % was 0.00% per year.

Operating Income or EBIT is linked to Return on Capital for both regular definition and Joel Greenblatt's definition. Kewaunee Scientific's annualized ROC % for the quarter that ended in Jan. 2024 was 12.36%. Kewaunee Scientific's annualized ROC (Joel Greenblatt) % for the quarter that ended in Jan. 2024 was 22.69%.


Kewaunee Scientific Operating Income Historical Data

The historical data trend for Kewaunee Scientific's Operating Income can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Kewaunee Scientific Operating Income Chart

Kewaunee Scientific Annual Data
Trend Apr14 Apr15 Apr16 Apr17 Apr18 Apr19 Apr20 Apr21 Apr22 Apr23
Operating Income
Get a 7-Day Free Trial Premium Member Only Premium Member Only 1.88 -2.16 -1.10 -2.42 4.89

Kewaunee Scientific Quarterly Data
Apr19 Jul19 Oct19 Jan20 Apr20 Jul20 Oct20 Jan21 Apr21 Jul21 Oct21 Jan22 Apr22 Jul22 Oct22 Jan23 Apr23 Jul23 Oct23 Jan24
Operating Income Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 2.12 2.51 3.41 4.80 3.46

Kewaunee Scientific Operating Income Calculation

Operating Income, is the profit a company earned through operations. All expenses, including cash expenses such as cost of goods sold (COGS), research & development, wages, and non-cash expenses, such as depreciation, depletion and amortization, have been deducted from the sales.

Operating Income for the trailing twelve months (TTM) ended in Jan. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was €14.2 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Kewaunee Scientific  (STU:KEW) Operating Income Explanation

1. Operating Income or EBIT is linked to Return on Capital for both regular definition and Joel Greenblatt's definition.

Kewaunee Scientific's annualized ROC % for the quarter that ended in Jan. 2024 is calculated as:

ROC % (Q: Jan. 2024 )
=NOPAT/Average Invested Capital
=Operating Income * ( 1 - Tax Rate % )/( (Invested Capital (Q: Oct. 2023 ) + Invested Capital (Q: Jan. 2024 ))/ count )
=13.824 * ( 1 - 27.92% )/( (83.301 + 77.948)/ 2 )
=9.9643392/80.6245
=12.36 %

where

Note: The Operating Income data used here is four times the quarterly (Jan. 2024) data.

2. Joel Greenblatt's definition of Return on Capital:

Kewaunee Scientific's annualized ROC (Joel Greenblatt) % for the quarter that ended in Jan. 2024 is calculated as:

ROC (Joel Greenblatt) %(Q: Jan. 2024 )
=EBIT/Average of (Net fixed Assets + Net Working Capital)
=EBIT/Average of (Property, Plant and Equipment+Net Working Capital)
     Q: Oct. 2023  Q: Jan. 2024
=EBIT/( ( (Property, Plant and Equipment + Net Working Capital) + (Property, Plant and Equipment + Net Working Capital) )/ count )
=14.416/( ( (24.837 + max(44.06, 0)) + (23.243 + max(34.932, 0)) )/ 2 )
=14.416/( ( 68.897 + 58.175 )/ 2 )
=14.416/63.536
=22.69 %

where Working Capital is:

Working Capital(Q: Oct. 2023 )
=(Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Defer. Rev. + Other Current Liabilities)
=(40.342 + 20.518 + 12.205) - (18.961 + 4.658 + 5.386)
=44.06

Working Capital(Q: Jan. 2024 )
=(Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Defer. Rev. + Other Current Liabilities)
=(37.738 + 20.054 + 10.915) - (18.436 + 9.408 + 5.931)
=34.932

When net working capital is negative, 0 is used.

Note: The EBIT data used here is four times the quarterly (Jan. 2024) EBIT data.

3. Operating Income is also linked to Operating Margin %:

Kewaunee Scientific's Operating Margin % for the quarter that ended in Jan. 2024 is calculated as:

Operating Margin %=Operating Income (Q: Jan. 2024 )/Revenue (Q: Jan. 2024 )
=3.456/42.942
=8.05 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

4. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Operating Income growth rate using Operating Income per share data.


Be Aware

Compared with a company's EBITDA margin, Operating Margin can be manipulated by adjusting the rate of depreciation, depletion and amortization (DDA).

If a company is facing competition, its Operating Margin may decline. Often the Operating Margin declines well before the company's revenue or even profit decline. Therefore, Operating Margin is a very important indicator of whether the company is facing problems.

For instance, by 2012, Nokia (NOK)'s problems were well known and its stock had lost more than 90% of its market value since 2007. But Nokia's Operating Margin had already been in decline since 2002, although its earnings per share were still rising. Investors who paid attention to Operating Margin would have avoided this huge loss. The same can be said for Research-in-Motion (RIMM).

Therefore, Operating Margin is a very important screening filter for GuruFocus. GuruFocus's Buffett-Munger screener requires that the profit margin is either consistent or expanding. The Model Portfolio of the Buffett-Munger screener has outperformed the market every year since inception in 2009.


Kewaunee Scientific Operating Income Related Terms

Thank you for viewing the detailed overview of Kewaunee Scientific's Operating Income provided by GuruFocus.com. Please click on the following links to see related term pages.


Kewaunee Scientific (STU:KEW) Business Description

Traded in Other Exchanges
Address
2700 West Front street, Statesville, NC, USA, 28677-2927
Kewaunee Scientific Corp is engaged in the design, manufacture, and installation of laboratory, healthcare, and technical furniture products. The company operates through two segments: Domestic and International. The Domestic business segment designs manufacture and install scientific and technical furniture, including steel and wood laboratory cabinetry, fume hoods, laminate casework, flexible systems, work surfaces, workstations, workbenches, and computer enclosures. The International business segment provides facility design, engineering, construction and project management from the planning stage through the testing and commissioning of laboratories. The company generates a majority of its revenue from the Domestic business segment.

Kewaunee Scientific (STU:KEW) Headlines

No Headlines